PIM
ZBH icon

Platinum Investment Management’s Zimmer Biomet ZBH Stock Holding History

Platinum Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,735
Closed -$1.02M – 154
2020
Q3 		$1.02M Sell
7,735
-2,852
-27% -$373K 0.03% 107
2020
Q2 		$1.23M Hold
10,587
– – 0.03% 105
2020
Q1 		$1.04M Buy
+10,587
New +$1.39M 0.03% 98

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Platinum Investment Management's ZBH Position: Q4 2020 in Review

Platinum Investment Management sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 7,735 shares — an estimated $1.02M sold.

Platinum Investment Management first reported a position in ZBH in Q1 2020 and held it in 3 quarters. The position peaked at $1.23M in Q2 2020. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Platinum Investment Management reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • Platinum Investment Management sold 7,735 Zimmer Biomet shares in Q4 2020, an estimated $1.02M.
  • Platinum Investment Management first reported a position in Zimmer Biomet in Q1 2020 and held it in 3 quarters.
  • Platinum Investment Management's Zimmer Biomet position peaked at $1.23M in Q2 2020.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Platinum Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.